Previous studies have identified cathepsin L (CTSL)-mediated EMT as a potential target to enhance the efficacy of cisplatin or paclitaxel in lung cancer and other malignancies, revealing that EMT cells exhibit a selective growth advantage in the presence of these drugs. This evidence concerns the gene CTSL and lung carcinoma.